Related Experiment Videos
Rapidly progressive IgA nephropathy
T R Welch1, A J McAdams, A Berry
1Department of Pediatrics, University of Cincinnati School of Medicine, OH.
Insights
Rapidly progressive glomerulonephritis in children, often IgA nephropathy (Berger's disease), leads to end-stage renal disease. Early detection and treatment are crucial as current therapies are ineffective in halting disease progression.
Area of Science:
- Pediatric Nephrology
- Immunopathology
- Glomerular Diseases
Background:
- IgA nephropathy (Berger's disease) is a common cause of glomerulonephritis.
- Rapidly progressive glomerulonephritis (RPGN) can lead to end-stage renal disease (ESRD).
- Understanding RPGN in pediatric populations is critical for effective management.
Observation:
- Five pediatric patients presented with RPGN and biopsy-confirmed IgA nephropathy.
- All patients exhibited mesangial IgA and C3 deposition, characteristic of Berger's disease.
- Severe hypertension and nephrotic syndrome were common comorbidities.
Findings:
- RPGN in these children progressed to ESRD despite characteristic IgA nephropathy findings.
- No specific clinical or laboratory marker differentiated these severe cases from uncomplicated IgA nephropathy.
- No therapeutic intervention halted the rapid decline in renal function.
Implications:
- This highlights a severe, aggressive form of IgA nephropathy in children.
- Current treatments for IgA nephropathy may not be effective for RPGN.
- Further research is needed to identify prognostic markers and effective therapies for pediatric RPGN.
Abstract:
Five children had rapidly progressive glomerulonephritis, determined by biopsy specimen and terminating in end-stage renal disease. All had mesangial deposition of IgA and C3 in the pattern typically seen with IgA nephropathy (Berger's disease). These children ranged in age from 7 to 13 years; four were boys. Severe hypertension was present in all, and three had a nephrotic syndrome. Other than hypertension and findings related to renal insufficiency or nephrotic syndrome, no clinical or laboratory finding was a consistent marker distinguishing these patients from those with uncomplicated IgA nephropathy, and no therapy proved useful in halting the rapid decline in renal function. The disease has not recurred in the kidney transplant of any of the five children.